Clinical characteristics and long-term surgical outcome of spinal myxopapillary ependymoma: a French cohort of 101 patients
- 23 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 152 (3), 491-499
- https://doi.org/10.1007/s11060-021-03717-7
Abstract
Purpose Myxopapillary ependymoma (MPE) is the most frequent tumor affecting the medullary conus. The surgical therapeutic management is still debated and only few studies have focused on the postoperative clinical outcome of patients. This study aimed to demonstrate long-term postoperative outcome and to assess the predictive factors of recurrence as well as the clinical evolution of these patients. Methods From 1984 to 2019, in four French centers, 101 adult patients diagnosed with MPE were retrospectively included. Results Median age at surgery was 39 years. Median tumor size was 50 mm and lesions were multifocal in 13% of patients. All patients benefited from surgery and one patient received postoperative radiotherapy. Gross total resection was obtained in 75% of cases. Sixteen percent of patients presented recurrence after a median follow-up of 70 months. Progression free survival at 5 and 10 years were respectively estimated at 83% and 79%. After multivariable analysis, sacral localization, and subtotal resection were shown to be independently associated with tumor recurrence. 85% of the patients had a favorable evolution concerning pain. 12% of the patients presented a postoperative deterioration of sphincter function and 4% of motor function. Conclusion Surgery alone is an acceptable option for MPE patients. Patients with sacral location or incomplete resection are at high risk of recurrence and should be carefully monitored.Keywords
This publication has 24 references indexed in Scilit:
- The Molecular Feature of HOX Gene Family in the Intramedullary Spinal TumorsSpine, 2017
- Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer NetworkNeuro-Oncology, 2014
- Outcomes After Surgery and Radiotherapy for Spinal Myxopapillary EpendymomaNeurosurgery, 2014
- Tumor control after surgery for spinal myxopapillary ependymomas: distinct outcomes in adults versus childrenJournal of Neurosurgery: Spine, 2013
- Unique Molecular Characteristics of Pediatric Myxopapillary EpendymomaBrain Pathology, 2010
- The Results of Surgery, With or Without Radiotherapy, for Primary Spinal Myxopapillary Ependymoma: A Retrospective Study From the Rare Cancer NetworkInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Spinal Myxopapillary EpendymomaSpine, 2009
- Expression profiling of ependymomas unravels localization and tumor grade‐specific tumorigenesisCancer, 2009
- Long term outcomes following surgical resection of myxopapillary ependymomasNeurosurgical Review, 2009
- Spinal myxopapillary ependymoma outcomes in patients treated with surgery and radiotherapy at M.D. Anderson Cancer CenterJournal of Neuro-Oncology, 2006